Enterprise Value
$11.35 B
-$321.90 M-2.76%
Fri, 21 Feb 2025 23:29:42 GMT
Summary
- As of February 22, 2025, SRPT enterprise value is $11.35 billion, with a fall of -$321.90 million (-2.76%) during the most recent trading day.
- Over the past year, SRPT enterprise value has dropped by -$2.02 billion (-15.09%).
- SRPT enterprise value is now -31.40% below its all-time high of $16.55 billion.
Performance
SRPT Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
SRPT Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -2.8% | -3.1% | -3.1% |
| 1 m1 month | -8.6% | -9.6% | -9.6% |
| 3 m3 months | -3.5% | -3.9% | -3.9% |
| 6 m6 months | -22.6% | -25.8% | -25.9% |
| ytdytd | -11.5% | -12.7% | -12.7% |
| 1 y1 year | -15.1% | -18.1% | -19.7% |
| 5 y5 years | +19.0% | +5.3% | -14.3% |
SRPT Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.8% | $11 B | +1.2% | |
| 3 m | 3-month | $14 B | -21.0% | $11 B | +1.2% |
| 6 m | 6-month | $15 B | -22.6% | $11 B | +3.3% |
| 1 y | 1-year | $17 B | -31.4% | $11 B | +3.3% |
| 3 y | 3-year | $17 B | -31.4% | $5.39 B | +110.6% |
| 5 y | 5-year | $17 B | -31.4% | $4.54 B | +150.1% |
| alltime | all time | $17 B | -31.4% | $18 M | >+9999.0% |
Sarepta Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $11.35 B(-11.5%) |
| 2024 | $12.82 B(+28.2%) |
| 2023 | $10.01 B(-16.9%) |
| 2022 | $12.05 B(+75.0%) |
| 2021 | $6.88 B(-47.5%) |
| 2020 | $13.10 B(+36.5%) |
| 2019 | $9.60 B(+22.9%) |
| 2018 | $7.81 B(+127.2%) |
| 2017 | $3.44 B(+146.2%) |
| 2016 | $1.40 B(-18.1%) |
| 2015 | $1.70 B(+221.1%) |
| 2014 | $530.55 M(+3.3%) |
| 2013 | $513.71 M(-18.7%) |
| 2012 | $632.05 M(+891.5%) |
| Date | Value |
|---|---|
| 2011 | $63.75 M(-69.1%) |
| 2010 | $206.52 M(+79.5%) |
| 2009 | $115.05 M(+199.9%) |
| 2008 | $38.36 M(-43.8%) |
| 2007 | $68.21 M(-54.2%) |
| 2006 | $148.96 M(+4.9%) |
| 2005 | $141.98 M(+107.9%) |
| 2004 | $68.28 M(-46.6%) |
| 2003 | $127.75 M(+4.3%) |
| 2002 | $122.43 M(-49.5%) |
| 2001 | $242.29 M(+217.7%) |
| 2000 | $76.27 M(-4.2%) |
| 1999 | $79.58 M(+77.3%) |
| 1998 | $44.88 M(-22.9%) |
| 1997 | $58.19 M |
FAQ
- What is Sarepta Therapeutics enterprise value?
- What is the all time high enterprise value for Sarepta Therapeutics?
- What is SRPT enterprise value year-to-date change?
- What is Sarepta Therapeutics enterprise value year-on-year change?
What is Sarepta Therapeutics enterprise value?
The current enterprise value of SRPT is $11.35 B
What is the all time high enterprise value for Sarepta Therapeutics?
Sarepta Therapeutics all-time high enterprise value is $16.55 B
What is SRPT enterprise value year-to-date change?
Sarepta Therapeutics enterprise value has changed by -$1.47 B (-11.49%) since the beginning of the year
What is Sarepta Therapeutics enterprise value year-on-year change?
Over the past year, SRPT enterprise value has changed by -$2.02 B (-15.09%)